Application of RUNX3 gene promoter methylation in the diagnosis of non-small cell lung cancer

Oncology Letters

Volumn 3, Issue 1, 2012, Pages 159-162

  Yu, Gui Ping ^a   Ji, Yong ^a   Guo Qiang, Chen ^a   Huang, Bin ^a   Shen, Kai ^a   Wu, Song ^a   Shen, Zhen Ya ^a  

^a JIANGYIN PEOPLE S HOSPITAL   (China)

Author keywords

Methylation; Non small cell lung cancer; Promoter; RUNX3

Indexed keywords

TRANSCRIPTION FACTOR RUNX3;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROTEIN ANALYSIS; PROTEIN METHYLATION; SMOKING HABIT; TUMOR DIFFERENTIATION;

EID: 84855217232     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2011.450     Document Type: Article

References (23)

1. Kim JS, Kim JW, Han J, Shim YM, Park J and Kim DH: Cohypermethylation of p16 and FHIT promoters as a prognostic factor of recurrence in surgically resected stage I non-small cell lung cancer. Cancer Res 66: 4049-4054, 2006.
2. Esteller M: Epigenetics provides a new generation of oncogenes and tumour-suppressor genes. Br J Cancer 94: 179-183, 2006.
3. Yamada Y, Jackson-Grusby L, Linhart H, Meissner A, Eden A, Lin H and Jaenisch R: Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis. Proc Natl Acad Sci USA 102: 13580-13585, 2005.
4. Carraway H and Herman J: Montoring methylation changes in caner. Methods Mol Biol 383: 187-202, 2007.
5. Chim CS, Liang R, Leung MH and Kwong YL: Aberrant gene methylation implicated in the progression of monoclonal gammopathy of undetermined significance to multiple myeloma. J Clin Pathol 60: 104-106, 2007.
6. Durst KL and Hiebert SW: Role of RUNX family members in transcriptional repression and gene silencing. Oncogene 23: 4220-4224, 2004.
7. Levanon D, Negreanu V, Bernstein Y, Bar-Am I, Avivi L and Groner Y: AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization. Genomics 23: 425-432, 1994.
8. Ito Y: Molecular basis of tissue-specific gene expression mediated by the runt domain transcription factor PEBP2/CBF. Genes Cells 4: 685-696, 1999.
9. Bae SC and Choi JK: Tumor suppressor activity of RUNX3. Oncogene 23: 4336-4340, 2004.
10. Miyazono K, Suzuki H and Imamura T: Regulation of TGF-beta signaling and its roles in progression of tumors. Cancer Sci 94: 230-234, 2003.
11. Blyth K, Cameron ER and Neil JC: The RUNX genes: gain or loss of function in cancer. Nat Rev Cancer 5: 376-387, 2005.
12. Jiang Y, Tong D, Lou G, Zhang Y and Geng J: Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines. Pathobiology 75: 244-251, 2008.
13. Kim EJ, Kim YJ, Jeong P, Ha YS, Bae SC and Kim WJ: Methylation of the RUNX3 promoter as a potential prognostic marker for bladder tumor. J Urol 180: 1141-1145, 2008.
14. Nomoto S, Kinoshita T, Mori T, Kato K, Sugimoto H, Kanazumi N, Takeda S and Nakao A: Adverse prognosis of epigenetic inactivation in RUNX3 gene at 1p36 in human pancreatic cancer. Br J Cancer 98: 1690-1695, 2008.
15. Waki T, Tamura G, Sato M, Terashima M, Nishizuka S and Motoyama T: Promoter methylation status of DAP-kinase and RUNX3 genes in neoplastic and non-neoplastic gastric epithelia. Cancer Sci 94: 360-364, 2003.
16. Friedrich MJ, Rad R, Langer R,Voland P, Hoefler H, Schmid RM, Prinz C and Gerhard M: Lack of RUNX3 regulation in human gastric cancer. J Pathol 210: 141-146, 2006.
17. Tan SH, Ida H, Lau QC, Goh BC, Chieng WS, Loh M and Ito Y: Detection of promoter hypermethylation in serum samples of cancer patients by methylation-specific polymerase chain reaction for tumour suppressor genes including RUNX3. Oncol Rep 18: 1225-1230, 2007.
18. Sato K, Tomizawa Y, Iijima H, Saito R, Ishizuka T, Nakajima T and Mori M: Epigenetic inactivation of the RUNX3 gene in lung cancer. Oncol Rep 15: 129-135, 2006.
19. Yanagawa N, Tamura G, Oizumi H, Kanauchi N, Endoh M, Sadahiro M and Motoyama T: Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers. Lung Cancer 5: 131-138, 2007.
20. Yanagawa N, Tamura G, Oizumi H, et al: Promoter hypermethylation of tumor suppressor and tumor-related genes in non-small cell lung cancers. Cancer Sci 94: 589-592, 2003.
21. Li QL, Kim HR, Kim WJ, Choi JK, Lee YH, Kim HM, Li LS, Kim H, Chang J, Ito Y, Youl Lee K and Bae SC: Transcriptional silencing of the RUNX3 gene by CpG hypermethylation is associated with lung cancer. Biochem Biophys Res Commun 314: 223-228, 2004.
22. Herranz M and Esteller M: DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets. Methods Mol Biol 361: 25-62, 2007.
23. Fojtova M, Piskala A, Votruba I, Otmar M, Bartova E and Kovarik A: Efficacy of DNA hypomethylating capacities of 5-aza-2'-deoxycytidine and its alpha anomer. Pharmacol Res 55: 16-22, 2007.